Download PDF
Journal of Pediatric Neurology
DOI: 10.1055/s-0044-1788054
Original Article

Comparison Efficacy of Phenobarbital versus Levetiracetam in Acute Neonatal Seizures: A Randomized Control Trial

Alireza Saadati
1   Clinical Research Development Unit, Department of Pediatrics, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran
,
Narges Kalhor
2   Student Research Committee, Department of Medicine, Qom University of Medical Sciences, Qom, Iran
,
Sara Afshari
2   Student Research Committee, Department of Medicine, Qom University of Medical Sciences, Qom, Iran
,
Masoud Hassanvand Amouzadeh
3   Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran
,
Mansoreh Saffari
1   Clinical Research Development Unit, Department of Pediatrics, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran
,
Mohsen Mollamohamadi
1   Clinical Research Development Unit, Department of Pediatrics, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Seizures in infancy are one of the main manifestations of disorders in the central nervous system that can have important etiologies. The development of anticonvulsant drugs and the importance of drug selection in infants, due to more complex underlying etiologies, compared with older ages, explicate the essentiality of executing clinical investigations to appraise the optimal therapeutic approach. The objective of the current investigation is to juxtapose two therapeutic approaches involving intravenous levetiracetam and intravenous phenobarbital in the management of neonatal seizures. This is a randomized controlled clinical trial study on 100 infants who were referred to the Hazrat Masoumeh (S) Hospital in Qom owing to convulsions. Infants with seizure who fulfilled the inclusion criteria were arbitrarily allocated to one of the two intervention cohorts: intravenous levetiracetam or intravenous phenobarbital, and therapeutic responses were compared. There was a substantial relationship between seizure time, seizure etiology, anticonvulsant therapy type, and treatment responsiveness. As a result, the risks of not responding to therapy and increasing the dose were approximately 6 and 5 times higher, respectively, in the group that experienced seizures in the fourth week than in the other groups. Infants with cerebrovascular anomalies were more prone to not responding to treatment. Furthermore, children administered phenobarbital had a 2.5-fold higher chance of not responding to treatment than those given levetiracetam (p = 0.043).

Keywords

levetiracetam - phenobarbital - neonatal seizures


Publication History

Received: 08 November 2023

Accepted: 01 June 2024

Article published online:
10 July 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Krawiec C, Muzio MR. Neonatal Seizure. In: StatPearls [Internet]. Treasure Island (FL):: StatPearls Publishing;; 2023
    Google Scholar
  • 2 Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med 2013; 18 (04) 185-191
    CrossrefPubMedGoogle Scholar
  • 3 Buraniqi E, Sansevere AJ, Kapur K, Bergin AM, Pearl PL, Loddenkemper T. Electrographic seizures in preterm neonates in the neonatal intensive care unit. J Child Neurol 2017; 32 (10) 880-885
    CrossrefPubMedGoogle Scholar
  • 4 Doty MS, Chen HY, Chauhan SP. Neonatal seizures among low-risk pregnancies at term: risk factors and adverse outcomes. Obstet Gynecol 2020; 135 (06) 1417-1425
    CrossrefPubMedGoogle Scholar
  • 5 Glass HC, Shellhaas RA, Wusthoff CJ. et al; Neonatal Seizure Registry Study Group. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr 2016; 174: 98-103.e1
    CrossrefPubMedGoogle Scholar
  • 6 Pressler RM, Cilio MR, Mizrahi EM. et al. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE task force on neonatal seizures. Epilepsia 2021; 62 (03) 615-628
    CrossrefPubMedGoogle Scholar
  • 7 Karimzadeh P, Taghdiri MM, Abasi E. et al. Metabolic screening in children with neurodevelopmental delay, seizure and/or regression. Iran J Child Neurol 2017; 11 (03) 42-47
    PubMedGoogle Scholar
  • 8 Poston JM, Rebholz A. Neonatal seizures: core concepts. Neonatal Netw 2021; 40 (06) 362-368
    CrossrefPubMedGoogle Scholar
  • 9 Ramantani G, Schmitt B, Plecko B. et al. Neonatal seizures-are we there yet?. Neuropediatrics 2019; 50 (05) 280-293
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Galanopoulou AS. GABA(A) receptors in normal development and seizures: friends or foes?. Curr Neuropharmacol 2008; 6 (01) 1-20
    CrossrefPubMedGoogle Scholar
  • 11 Ansari AH, Cherian PJ, Caicedo A, Naulaers G, De Vos M, Van Huffel S. Neonatal seizure detection using deep convolutional neural networks. Int J Neural Syst 2019; 29 (04) 1850011
    CrossrefPubMedGoogle Scholar
  • 12 Pavel AM, Rennie JM, de Vries LS. et al. Neonatal seizure management: is the timing of treatment critical?. J Pediatr 2022; 243: 61-68.e2
    CrossrefPubMedGoogle Scholar
  • 13 Samanta D. Recent advances in the diagnosis and treatment of neonatal seizures. Neuropediatrics 2021; 52 (02) 73-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Swami M, Kaushik JS. Levetiracetam in neonatal seizures. Indian Pediatr 2019; 56 (08) 639-640
    CrossrefPubMedGoogle Scholar
  • 15 Painter MJ, Scher MS, Stein AD. et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341 (07) 485-489
    CrossrefPubMedGoogle Scholar
  • 16 Boylan GB, Rennie JM, Pressler RM, Wilson G, Morton M, Binnie CD. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed 2002; 86 (03) F165-F170
    CrossrefPubMedGoogle Scholar
  • 17 Vegda H, Krishnan V, Variane G, Bagayi V, Ivain P, Pressler RM. Neonatal seizures—perspective in low- and middle-income countries. Indian J Pediatr 2022; 89 (03) 245-253
    CrossrefPubMedGoogle Scholar
  • 18 Li J, Yang YX, Chen X. et al. The random and comparative study on therapeutic effect and safety between levetiracetam and phenobarbital administration for neonatal seizures. Zhonghua Shiyong Erke Linchuang Zazhi 2016; 12: 910-914
    PubMedGoogle Scholar
  • 19 Gowda VK, Romana A, Shivanna NH, Benakappa N, Benakappa A. Levetiracetam versus phenobarbitone in neonatal seizures—a randomized controlled trial. Indian Pediatr 2019; 56 (08) 643-646
    CrossrefPubMedGoogle Scholar
  • 20 Pervez AF, Badal MFA, Nabi SN. et al. Randomized controlled trial between levetiracetam and phenobarbital in the treatment of neonatal seizure due to perinatal asphyxia. Bangladesh J Child Health 2018; 42 (67–72): 26
    CrossrefPubMedGoogle Scholar
  • 21 Gyandeep G, Behura SS, Sahu SK, Panda SK. Comparison between Phenobarbitone and Levetiracetam as the initial anticonvulsant in preterm neonatal seizures - a pilot randomized control trial in developing country setup. Eur J Pediatr 2023; 182 (05) 2133-2138
    CrossrefPubMedGoogle Scholar
  • 22 Susnerwala S, Joshi A, Deshmukh L, Londhe A. Levetiracetam or phenobarbitone as a first-line anticonvulsant in asphyxiated term newborns? An open-label, single-center, randomized, controlled, pragmatic trial. Hosp Pediatr 2022; 12 (07) 647-653
    CrossrefPubMedGoogle Scholar
  • 23 Bättig L, Dünner C, Cserpan D. et al. Levetiracetam versus phenobarbital for neonatal seizures: a retrospective cohort study. Pediatr Neurol 2023; 138: 62-70
    CrossrefPubMedGoogle Scholar
  • 24 Akeel NE, Suliman HA, Al-Shokary AH. et al. A comparative study of levetiracetam and phenobarbital for neonatal seizures as a first line treatment. Glob Pediatr Health 2022; 9: 2333794 × 221143572
    PubMedGoogle Scholar
  • 25 Verwoerd C, Limjoco J, Rajamanickam V, Knox A. Efficacy of levetiracetam and phenobarbital as first-line treatment for neonatal seizures. J Child Neurol 2022; 37 (05) 401-409
    CrossrefPubMedGoogle Scholar
  • 26 Thibault C, Naim MY, Abend NS. et al. A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates. Epilepsia 2020; 61 (04) 627-635
    CrossrefPubMedGoogle Scholar
  • 27 Wagner CB, Kreimer AM, Carrillo NP. et al. Levetiracetam compared to phenobarbital as a first line therapy for neonatal seizures: an unexpected influence of benzodiazepines on seizure response. J Pediatr Pharmacol Ther 2021; 26 (02) 144-150
    CrossrefPubMedGoogle Scholar
  • 28 Tan HY. Clinical comparative analysis of levetiracetam and phenobarbital in treatment of neonatal convulsions. Digest World Latest Med Inf 2019; 51: 18-19
    PubMedGoogle Scholar
  • 29 Prakash A, Richa R, Sahni GS. Neonatal seizures—levetiracetam versus phenobarbital. Indian J Child Health (Bhopal) 2019; 6 (11) 605-608
    CrossrefPubMedGoogle Scholar
  • 30 Sharpe C, Reiner GE, Davis SL. et al; NEOLEV2 INVESTIGATORS. NEOLEV2 Investigators. Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial. Pediatrics 2020; 145 (06) e20193182
    CrossrefPubMedGoogle Scholar
  • 31 Perveen S, Singh A, Upadhyay A. et al. A randomized controlled trial on comparison of phenobarbitone and levetiracetam for the treatment of neonatal seizures: pilot study. Int J Res Med Sci 2016; 4: 2073-2078
    CrossrefPubMedGoogle Scholar
  • 32 El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med 2017; 22 (05) 321-327
    CrossrefPubMedGoogle Scholar
  • 33 Cornet MC, Morabito V, Lederer D. et al. Neonatal presentation of genetic epilepsies: early differentiation from acute provoked seizures. Epilepsia 2021; 62 (08) 1907-1920
    CrossrefPubMedGoogle Scholar